G&W Laboratories, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
G&W Laboratories, Inc. - overview
Established
1919
Location
South Plainfield, NJ, US
Primary Industry
Pharmaceuticals
About
G&W Laboratories, Inc. is a pharmaceutical company dedicated to developing and producing effective medications to improve patient health. They focus on delivering quality prescription and over-the-counter products across various therapeutic areas. Founded in 1919 and headquartered in South Plainfield, US, G&W Laboratories, Inc.
specializes in pharmaceutical manufacturing. The company was established by individuals whose specific details are not publicly available. Aaron Greenblatt currently serves as the CEO, leading the firm in its operations and growth strategies. G&W Laboratories, Inc.
specializes in the production of pharmaceutical products that aim to alleviate human suffering through effective treatments. Their core offerings include a range of high-quality prescription medications and over-the-counter products that cater to various therapeutic areas, including pain management, anti-infectives, and specialty pharmaceuticals. The company’s products are designed for healthcare providers, pharmacies, and hospitals, ensuring accessibility for patients who rely on these medications for their well-being. G&W Laboratories serves a diverse client base across multiple geographical markets, including North America, Europe, and select regions in Asia, thus broadening the impact of their offerings in global healthcare.
By continually adapting to market demands, the company maintains a focus on improving patient outcomes through innovative solutions tailored to specific health needs. G&W Laboratories generates revenue primarily through the sale of its pharmaceutical products, which are distributed to healthcare providers and retail pharmacies. The transaction structure typically involves direct sales to clients, with partnerships formed with healthcare facilities and wholesalers to enhance product accessibility. These transactions may incorporate bulk purchasing agreements or volume-based pricing strategies, facilitating cost-effective solutions for large healthcare institutions.
While specific pricing plans are not disclosed, the company’s flagship products likely command premium pricing due to their quality and effectiveness in treating health conditions. The company’s revenue model underscores its commitment to delivering value, ensuring that clients receive reliable products while addressing the challenges associated with patient care.
Primary Industry
Pharmaceuticals
Sub Industries
Beauty & Hygiene, Pharmaceutical Research & Development
Website
www.gwlabs.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
G&W Laboratories, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Carve Out | Completed | Cosette Pharmaceuticals, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.